Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Methadone for Cancer-related Breakthrough Pain
NCT00351715Phase 2Terminated
- Sponsor
- American Health Staffing Group
- Start
- Jul 2008
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methadone in breakthrough pain, sponsored by American Health Staffing Group. Primary endpoint: Feasibility of the dose titration and assessment protocol at 12 months. Started Jul 2008; status: terminated.
02
Drugs
methadone
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00351715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351715.